{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:37:27Z","timestamp":1793947047896,"version":"4.8.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1245\/s10434-025-17358-x","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T09:11:18Z","timestamp":1750842678000},"page":"5125-5141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Consensus Guideline for the Management of Peritoneal Mesothelioma"],"prefix":"10.1245","volume":"33","author":[{"given":"Leanne M.","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah G.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun V.","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Gomez-Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran K.","family":"Turaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig G.","family":"Gunderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byrne","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett M.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanwal P.","family":"Raghav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya L.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Kluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie G.","family":"Zauderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedy L.","family":"Kindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Richard","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Peritoneal Surface Malignancies (PSM) Consortium Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Khader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Marchevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alda","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander S.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Gangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Arrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anai","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Govindarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Nikiforchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Blakely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Churg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"\u0141owy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Villano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Bouchard-Fortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwaar","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baylee","family":"Bakkila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Powers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Helmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biren","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Sparkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Hester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Harmath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Luu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Staley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chukwuemeka","family":"Ihemelandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Brottman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Pameijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Court","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conor","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Blazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Labow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Milgrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Outlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Schuitevoerder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Chapel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Magge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon","family":"Freudenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyali","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Olecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Papai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Pletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin P.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Lopez-Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Forest","family":"Mahoney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick A.","family":"Godley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary N.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Salti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Georgakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Karagkounis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilbert","family":"Murimwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgos","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hallbera","family":"Gudmundsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harveshp","family":"Mogal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunter","family":"Witmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Konstantinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Baril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyne J.","family":"Gaddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"James Cusack","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javid","family":"Sadjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Sharib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Buchheit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Paul","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Greer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Dowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jula","family":"Veerapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Chouliaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Votanopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina A.","family":"Matkowskyj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Raymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Schleimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindy","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloyd","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian","family":"Chirieac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Talha","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline B.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheswari","family":"Senthil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcovalerio","family":"Melis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Garland-Kledzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mason","family":"Vierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Ghayouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gubens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazin","family":"Al-Kasspooles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mecker","family":"Moller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehraneh D.","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ongchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Taggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Offin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika\u00ebl","family":"Soucisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Haroon Asif","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Suraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Malec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Raoof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Wasif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nad\u00e8ge","family":"Fackche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Bhutiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelya","family":"Melnitchouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj J.","family":"Gusani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pathik","family":"Aravind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Polanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Helft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sugarbaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pompiliu","family":"Piso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Pandalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachyl","family":"Shanker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raed","family":"Al-Rajabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghav","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wiatrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Attanoos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Berri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hoehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Royal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riom","family":"Kwakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Akumuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sticca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupen","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Merkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabha","family":"Ganai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam George","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Ruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer","family":"Naffouje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Butensky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Bagaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Dineen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Concors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Radomski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Abdel-Misih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Ryum","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Libutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Clark","family":"Gamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Jaraczewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thinzar","family":"Lwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Grotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugwuji","family":"Maduekwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Sarpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uqba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vignesh","family":"Vudatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Chin","family":"Foo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbur B.","family":"Bowne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Keutgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"17358_CR1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.21037\/atm.2017.03.96","volume":"5","author":"J Kim","year":"2017","unstructured":"Kim J, Bhagwandin S, Labow DM. Malignant peritoneal mesothelioma: a review. Ann Transl Med. 2017;5:236.","journal-title":"Ann Transl Med"},{"key":"17358_CR2","first-page":"935","volume":"20","author":"SH Moolgavkar","year":"2009","unstructured":"Moolgavkar SH, Meza R, Turim J. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973\u20132005. Cancer Causes Control. 2009;20:935\u201344.","journal-title":"Cancer Causes Control"},{"key":"17358_CR3","first-page":"32","volume":"9","author":"A Bridda","year":"2007","unstructured":"Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal mesothelioma: a review. MedGenMed Medscape Gen Med. 2007;9:32.","journal-title":"MedGenMed Medscape Gen Med."},{"key":"17358_CR4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1245\/s10434-013-3358-y","volume":"21","author":"D Magge","year":"2014","unstructured":"Magge D, et al. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis. Ann Surg Oncol. 2014;21:1159\u201365.","journal-title":"Ann Surg Oncol."},{"key":"17358_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.ejso.2008.09.010","volume":"35","author":"H Yano","year":"2009","unstructured":"Yano H, Moran BJ, Cecil TD, Murphy EM. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Eur J Surg Oncol EJSO. 2009;35:980\u20135.","journal-title":"Eur J Surg Oncol. EJSO"},{"key":"17358_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11547-016-0682-x","volume":"122","author":"A Laghi","year":"2017","unstructured":"Laghi A, et al. Diagnostic performance of computed tomography and magnetic resonance imaging for detecting peritoneal metastases: systematic review and meta-analysis. Radiol Med (Torino). 2017;122:1\u201315.","journal-title":"Radiol Med (Torino)"},{"key":"17358_CR7","first-page":"36","volume":"47","author":"S Kusamura","year":"2021","unstructured":"Kusamura S, et al. Peritoneal mesothelioma: PSOGI\/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2021;47:36\u201359.","journal-title":"Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"17358_CR8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.canep.2019.03.014","volume":"60","author":"N Le Stang","year":"2019","unstructured":"Le Stang N, et al. Incidence and survival of peritoneal malignant mesothelioma between 1989 and 2015: a population-based study. Cancer Epidemiol. 2019;60:106\u201311.","journal-title":"Cancer Epidemiol."},{"key":"17358_CR9","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.21037\/tlcr.2019.12.15","volume":"9","author":"A Greenbaum","year":"2020","unstructured":"Greenbaum A, Alexander HR. Peritoneal mesothelioma. Transl Lung Cancer Res. 2020;9:S120\u201332.","journal-title":"Transl. Lung Cancer Res."},{"key":"17358_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.6004\/jnccn.2012.0008","volume":"10","author":"K Turner","year":"2012","unstructured":"Turner K, Varghese S, Alexander HR. Current concepts in the evaluation and treatment of patients with diffuse malignant peritoneal mesothelioma. J Natl Compr Cancer Netw JNCCN. 2012;10:49\u201357.","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"17358_CR11","doi-asserted-by":"publisher","unstructured":"Group PW, Group PC, Turaga KK. Consensus Guidelines for the Management of Peritoneal Surface Malignancies: Introduction and Methodology. 2024.04.07.24305467 Preprint at https:\/\/doi.org\/10.1101\/2024.04.07.24305467 (2024).","DOI":"10.1101\/2024.04.07.24305467"},{"key":"17358_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5596\/c14-016","volume":"35","author":"J Babineau","year":"2014","unstructured":"Babineau J. Product Review: Covidence (Systematic Review Software). J Can Health Libr Assoc J Assoc Bibl Sant\u00e9 Can. 2014;35:68\u201371.","journal-title":"J. Can. Health Libr. Assoc. J. Assoc. Bibl. Sant\u00e9 Can."},{"key":"17358_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2288-8-22","volume":"8","author":"A Lundh","year":"2008","unstructured":"Lundh A, G\u00f8tzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol. 2008;8:22.","journal-title":"BMC Med. Res. Methodol."},{"key":"17358_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/pst.2068","volume":"20","author":"C Luchini","year":"2021","unstructured":"Luchini C, et al. Assessing the quality of studies in meta-research: Review\/guidelines on the most important quality assessment tools. Pharm Stat. 2021;20:185\u201395.","journal-title":"Pharm. Stat."},{"key":"17358_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jclinepi.2020.10.007","volume":"130","author":"C Garritty","year":"2021","unstructured":"Garritty C, et al. Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. J Clin Epidemiol. 2021;130:13\u201322.","journal-title":"J. Clin. Epidemiol."},{"key":"17358_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"key":"17358_CR17","doi-asserted-by":"publisher","unstructured":"The Chicago Consensus on peritoneal surface malignancies: Management of peritoneal mesothelioma - - 2020 - Cancer - Wiley Online Library. https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1002\/cncr.32870.","DOI":"10.1002\/cncr.32870"},{"key":"17358_CR18","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2214\/AJR.07.3628","volume":"191","author":"JY Park","year":"2008","unstructured":"Park JY, et al. Peritoneal mesotheliomas: clinicopathologic features, CT findings, and differential diagnosis. AJR Am J Roentgenol. 2008;191:814\u201325.","journal-title":"AJR Am. J. Roentgenol."},{"key":"17358_CR19","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1309\/AJCPHSUJ15NEYMIP","volume":"130","author":"Y Takeshima","year":"2008","unstructured":"Takeshima Y, Amatya VJ, Kushitani K, Inai K. A useful antibody panel for differential diagnosis between peritoneal mesothelioma and ovarian serous carcinoma in Japanese cases. Am J Clin Pathol. 2008;130:771\u20139.","journal-title":"Am. J. Clin. Pathol."},{"key":"17358_CR20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1245\/s10434-012-2236-3","volume":"19","author":"RN Low","year":"2012","unstructured":"Low RN, Barone RM. Combined diffusion-weighted and gadolinium-enhanced MRI can accurately predict the peritoneal cancer index preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol. 2012;19:1394\u2013401.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1080\/02656736.2017.1320591","volume":"33","author":"KK Turaga","year":"2017","unstructured":"Turaga KK, Deraco M, Alexander HR. Current management strategies for peritoneal mesothelioma. Int J Hyperth Off J Eur Soc Hyperthermic Oncol North Am Hyperth Group. 2017;33:579\u201381.","journal-title":"Int. J. Hyperth. Off. J. Eur. Soc. Hyperthermic Oncol. North Am. Hyperth. Group"},{"key":"17358_CR22","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12885-020-6648-3","volume":"20","author":"M Drevinskaite","year":"2020","unstructured":"Drevinskaite M, Patasius A, Kevlicius L, Mickys U, Smailyte G. Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature. BMC Cancer. 2020;20:162.","journal-title":"BMC Cancer"},{"key":"17358_CR23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jso.21055","volume":"98","author":"M Deraco","year":"2008","unstructured":"Deraco M, Bartlett D, Kusamura S, Baratti D. Consensus statement on peritoneal mesothelioma. J Surg Oncol. 2008;98:268\u201372.","journal-title":"J. Surg. Oncol."},{"key":"17358_CR24","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/MNM.0000000000000649","volume":"38","author":"J Dubreuil","year":"2017","unstructured":"Dubreuil J, et al. The role of 18F-FDG-PET\/ceCT in peritoneal mesothelioma. Nucl Med Commun. 2017;38:312.","journal-title":"Nucl. Med. Commun."},{"key":"17358_CR25","unstructured":"Amin M. AJCC Cancer Staging Manual (8th ed.). Springer. 2017; https:\/\/cancerstaging.org\/references-tools\/deskreferences\/Pages\/default.aspx."},{"key":"17358_CR26","doi-asserted-by":"publisher","first-page":"599","DOI":"10.21037\/tlcr.2018.08.03","volume":"7","author":"PH Sugarbaker","year":"2018","unstructured":"Sugarbaker PH. Update on the management of malignant peritoneal mesothelioma. Transl Lung Cancer Res. 2018;7:599\u2013608.","journal-title":"Transl. Lung Cancer Res."},{"key":"17358_CR27","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.2147\/CMAR.S170300","volume":"11","author":"LM Enomoto","year":"2019","unstructured":"Enomoto LM, Shen P, Levine EA, Votanopoulos KI. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: patient selection and special considerations. Cancer Manag Res. 2019;11:4231\u201341.","journal-title":"Cancer Manag. Res."},{"key":"17358_CR28","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1055-3207(03)00045-0","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH, Welch LS, Mohamed F, Glehen O. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am. 2003;12:605\u201321.","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"17358_CR29","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1309\/DV1JYBL8LLYYT4J5","volume":"128","author":"NP Patel","year":"2007","unstructured":"Patel NP, Taylor CA, Levine EA, Trupiano JK, Geisinger KR. Cytomorphologic features of primary peritoneal mesothelioma in effusion, washing, and fine-needle aspiration biopsy specimens: examination of 49 cases at one institution, including post-intraperitoneal hyperthermic chemotherapy findings. Am J Clin Pathol. 2007;128:414\u201322.","journal-title":"Am. J. Clin. Pathol."},{"key":"17358_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2017","unstructured":"Husain AN, et al. Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med. 2017;142:89\u2013108.","journal-title":"Arch. Pathol. Lab. Med."},{"key":"17358_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s12876-022-02361-3","volume":"22","author":"D Pan","year":"2022","unstructured":"Pan D, et al. Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly. BMC Gastroenterol. 2022;22:292.","journal-title":"BMC Gastroenterol."},{"key":"17358_CR32","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41379-020-00688-4","volume":"34","author":"DB Chapel","year":"2021","unstructured":"Chapel DB, et al. Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases. Mod Pathol. 2021;34:380\u201395.","journal-title":"Mod. Pathol."},{"key":"17358_CR33","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1245\/s10434-015-4962-9","volume":"23","author":"S Kusamura","year":"2016","unstructured":"Kusamura S, Torres Mesa PA, Cabras A, Baratti D, Deraco M. The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). Ann Surg Oncol. 2016;23:1468\u201373.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1097\/COC.0b013e3182a0e867","volume":"38","author":"K Pillai","year":"2015","unstructured":"Pillai K, Pourgholami MH, Chua TC, Morris DL. Prognostic significance of Ki67 expression in malignant peritoneal mesothelioma. Am J Clin Oncol. 2015;38:388\u201394.","journal-title":"Am. J. Clin. Oncol."},{"key":"17358_CR35","doi-asserted-by":"publisher","first-page":"175883592096236","DOI":"10.1177\/1758835920962362","volume":"12","author":"L Jin","year":"2020","unstructured":"Jin L, et al. PD-L1 and prognosis in patients with malignant pleural mesothelioma: a meta-analysis and bioinformatics study. Ther Adv Med Oncol. 2020;12:1758835920962362.","journal-title":"Ther. Adv. Med. Oncol."},{"key":"17358_CR36","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.jtho.2017.03.018","volume":"12","author":"S Lantuejoul","year":"2017","unstructured":"Lantuejoul S, Stang NL, Damiola F, Scherpereel A, Galateau-Sall\u00e9 F. PD-L1 testing for immune checkpoint inhibitors in mesothelioma: For want of anything better? J Thorac Oncol. 2017;12:778\u201381.","journal-title":"J. Thorac. Oncol."},{"key":"17358_CR37","doi-asserted-by":"publisher","first-page":"S339","DOI":"10.1016\/j.jtho.2018.08.277","volume":"13","author":"A Desai","year":"2018","unstructured":"Desai A, et al. OA08.03 Phase II Trial of Pembrolizumab (NCT02399371) In Previously-Treated Malignant Mesothelioma (MM): Final Analysis. J Thorac Oncol. 2018;13:S339.","journal-title":"J. Thorac. Oncol."},{"key":"17358_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S2213-2600(20)30515-4","volume":"9","author":"TA Yap","year":"2021","unstructured":"Yap TA, et al. Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study. Lancet Respir Med. 2021;9:613\u201321.","journal-title":"Lancet Respir. Med."},{"key":"17358_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jamaoncol.2017.2918","volume":"4","author":"YP Hung","year":"2018","unstructured":"Hung YP, et al. Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma. JAMA Oncol. 2018;4:235\u20138.","journal-title":"JAMA Oncol."},{"key":"17358_CR40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1245\/s10434-008-0219-1","volume":"16","author":"D Baratti","year":"2009","unstructured":"Baratti D, et al. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC). Ann Surg Oncol. 2009;16:463\u201372.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR41","doi-asserted-by":"publisher","first-page":"915","DOI":"10.21037\/jgo.2017.08.01","volume":"8","author":"A Garc\u00eda-Fadrique","year":"2017","unstructured":"Garc\u00eda-Fadrique A, et al. Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review. J Gastrointest Oncol. 2017;8:915\u201324.","journal-title":"J. Gastrointest. Oncol."},{"key":"17358_CR42","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jtho.2022.03.014","volume":"17","author":"M Carbone","year":"2022","unstructured":"Carbone M, et al. Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations. J Thorac Oncol. 2022;17:873\u201389.","journal-title":"J. Thorac. Oncol."},{"key":"17358_CR43","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12967-018-1559-7","volume":"16","author":"M Kittaneh","year":"2018","unstructured":"Kittaneh M, Berkelhammer C. Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members. J Transl Med. 2018;16:194.","journal-title":"J. Transl. Med."},{"key":"17358_CR44","doi-asserted-by":"publisher","first-page":"2863","DOI":"10.1200\/JCO.2018.78.5204","volume":"36","author":"V Panou","year":"2018","unstructured":"Panou V, et al. Frequency of germline mutations in cancer susceptibility genes in malignant mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol. 2018;36:2863\u201371.","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"17358_CR45","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet. 2011;43:1022\u20135.","journal-title":"Nat. Genet."},{"key":"17358_CR46","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.jtho.2021.09.012","volume":"17","author":"M Offin","year":"2022","unstructured":"Offin M, et al. Molecular characterization of peritoneal mesotheliomas. J Thorac Oncol. 2022;17:455\u201360.","journal-title":"J. Thorac. Oncol."},{"key":"17358_CR47","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1038\/s41416-022-01979-0","volume":"127","author":"S Hiltbrunner","year":"2022","unstructured":"Hiltbrunner S, et al. Genomic landscape of pleural and peritoneal mesothelioma tumours. Br J Cancer. 2022;127:1997\u20132005.","journal-title":"Br. J. Cancer"},{"key":"17358_CR48","unstructured":"Pappas CP et al. Massive peritoneal inclusion cyst with secondary abscessation. Surg. Pract. n\/a,."},{"key":"17358_CR49","doi-asserted-by":"publisher","first-page":"583","DOI":"10.5603\/GP.a2021.0142","volume":"92","author":"A Natkanska","year":"2021","unstructured":"Natkanska A, Bizon-Szpernalowska MA, Milek T, Sawicki W. Peritoneal inclusion cysts as a diagnostic and treatment challenge. Ginekol Pol. 2021;92:583\u20136.","journal-title":"Ginekol. Pol."},{"key":"17358_CR50","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00404-018-4728-2","volume":"297","author":"AMC Rapisarda","year":"2018","unstructured":"Rapisarda AMC, et al. Benign multicystic mesothelioma and peritoneal inclusion cysts: are they the same clinical and histopathological entities? A systematic review to find an evidence-based management. Arch Gynecol Obstet. 2018;297:1353\u201375.","journal-title":"Arch. Gynecol. Obstet."},{"key":"17358_CR51","first-page":"e35230","volume":"15","author":"JO AlTamimi","year":"2023","unstructured":"AlTamimi JO, Alzahrani EA, Fallatah A, Alhakami LA, Bokhari BE. Peritoneal inclusion cyst in a young patient with a long history of abdominal surgeries: a case report. Cureus. 2023;15:e35230.","journal-title":"Cureus"},{"key":"17358_CR52","doi-asserted-by":"publisher","DOI":"10.4322\/acr.2020.159","volume":"10","author":"MT Chand","year":"2020","unstructured":"Chand MT, Edens J, Lin T, Anderson I, Berri R. Benign multicystic peritoneal mesothelioma: literature review and update. Autopsy Case Rep. 2020;10:e2020159.","journal-title":"Autopsy Case Rep."},{"key":"17358_CR53","doi-asserted-by":"publisher","DOI":"10.1148\/rg.220128","volume":"43","author":"A Bonde","year":"2023","unstructured":"Bonde A, et al. Mesotheliomas and benign mesothelial tumors: update on pathologic and imaging findings. RadioGraphics. 2023;43:e220128.","journal-title":"RadioGraphics"},{"key":"17358_CR54","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/PAS.0000000000002033","volume":"47","author":"F Galateau-Salle","year":"2023","unstructured":"Galateau-Salle F, et al. Mesothelioma in situ mimicking well-differentiated papillary mesothelial tumor. Am J Surg Pathol. 2023;47:611\u20137.","journal-title":"Am. J. Surg. Pathol."},{"key":"17358_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ygyno.2005.03.031","volume":"98","author":"AV Hoekstra","year":"2005","unstructured":"Hoekstra AV, Riben MW, Frumovitz M, Liu J, Ramirez PT. Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature. Gynecol Oncol. 2005;98:161\u20137.","journal-title":"Gynecol. Oncol."},{"key":"17358_CR56","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1097\/00000478-200110000-00012","volume":"25","author":"KJ Butnor","year":"2001","unstructured":"Butnor KJ, Sporn TA, Hammar SP, Roggli VL. Well-differentiated papillary mesothelioma. Am J Surg Pathol. 2001;25:1304.","journal-title":"Am. J. Surg. Pathol."},{"key":"17358_CR57","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/cancers12061568","volume":"12","author":"R Shrestha","year":"2020","unstructured":"Shrestha R, et al. Well-differentiated papillary mesothelioma of the peritoneum is genetically distinct from malignant mesothelioma. Cancers. 2020;12:1568.","journal-title":"Cancers"},{"key":"17358_CR58","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/s41379-022-01082-y","volume":"35","author":"A Churg","year":"2022","unstructured":"Churg A, Galateau-Salle F. Well differentiated papillary mesothelial tumor: a new name and new problems. Mod Pathol. 2022;35:1327\u201333.","journal-title":"Mod. Pathol."},{"key":"17358_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.anndiagpath.2018.10.012","volume":"38","author":"M Sun","year":"2019","unstructured":"Sun M, Zhao L, Weng Lao I, Yu L, Wang J. Well-differentiated papillary mesothelioma: a 17-year single institution experience with a series of 75 cases. Ann Diagn Pathol. 2019;38:43\u201350.","journal-title":"Ann. Diagn. Pathol."},{"key":"17358_CR60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41379-019-0347-0","volume":"33","author":"A Churg","year":"2020","unstructured":"Churg A, et al. Malignant mesothelioma in situ: morphologic features and clinical outcome. Mod Pathol. 2020;33:297\u2013302.","journal-title":"Mod. Pathol."},{"key":"17358_CR61","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/his.15092","volume":"84","author":"E Symes","year":"2024","unstructured":"Symes E, et al. Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. Histopathology. 2024;84:492\u2013506.","journal-title":"Histopathology"},{"key":"17358_CR62","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/PGP.0000000000000832","volume":"41","author":"DR FelsElliott","year":"2022","unstructured":"FelsElliott DR, et al. Progression of peritoneal mesothelioma in situ to invasive mesothelioma arising in the setting of endometriosis with germline BAP1 mutation: a case report. Int J Gynecol Pathol Off J Int Soc Gynecol Pathol. 2022;41:535\u201340.","journal-title":"Int. J. Gynecol. Pathol. Off. J. Int. Soc. Gynecol. Pathol."},{"key":"17358_CR63","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/pin.13021","volume":"70","author":"K Hidaka","year":"2020","unstructured":"Hidaka K, et al. Development of mesothelioma in situ and its progression to invasive disease observed in a patient with uncontrolled pleural effusions for 15 years. Pathol Int. 2020;70:1009\u201314.","journal-title":"Pathol. Int."},{"key":"17358_CR64","doi-asserted-by":"publisher","first-page":"220","DOI":"10.5090\/jcs.22.107","volume":"56","author":"M Abdelghafar","year":"2023","unstructured":"Abdelghafar M, et al. Well-differentiated papillary mesothelial tumor: an unusual radiologic presentation: a case report. J Chest Surg. 2023;56:220\u20133.","journal-title":"J. Chest Surg."},{"key":"17358_CR65","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","volume":"36","author":"A Malpica","year":"2012","unstructured":"Malpica A, Sant\u2019Ambrogio S, Deavers MT, Silva EG. Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases. Am J Surg Pathol. 2012;36:117.","journal-title":"Am. J. Surg. Pathol."},{"key":"17358_CR66","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1245\/s10434-007-9475-8","volume":"14","author":"D Baratti","year":"2007","unstructured":"Baratti D, et al. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC). Ann Surg Oncol. 2007;14:2790\u20137.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/030089160308900107","volume":"89","author":"K Sethna","year":"2003","unstructured":"Sethna K, Mohamed F, Marchettini P, Elias D, Sugarbaker PH. Peritoneal cystic mesothelioma: a case series. Tumori. 2003;89:31\u20135.","journal-title":"Tumori"},{"key":"17358_CR68","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1093\/jjco\/hyt117","volume":"43","author":"YK Lee","year":"2013","unstructured":"Lee YK, et al. Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum. Jpn J Clin Oncol. 2013;43:996\u20131003.","journal-title":"Jpn. J. Clin. Oncol."},{"key":"17358_CR69","first-page":"604","volume":"46","author":"S Liu","year":"2014","unstructured":"Liu S, Staats P, Lee M, Alexander HR, Burke AP. Diffuse mesothelioma of the peritoneum: correlation between histological and clinical parameters and survival in 73 patients. Pathology (Phila). 2014;46:604\u20139.","journal-title":"Pathology (Phila.)"},{"key":"17358_CR70","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1245\/s10434-012-2845-x","volume":"20","author":"M Deraco","year":"2013","unstructured":"Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2013;20:1093\u2013100.","journal-title":"Ann. Surg. Oncol."},{"issue":"65","key":"17358_CR71","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2016.06.002","volume":"1990","author":"V Kepenekian","year":"2016","unstructured":"Kepenekian V, et al. Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database: multi-Institutional Retrospective Study. Eur J Cancer Oxf Engl. 2016;1990(65):69\u201379.","journal-title":"Eur. J. Cancer Oxf. Engl."},{"key":"17358_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0275187","volume":"17","author":"X Wang","year":"2022","unstructured":"Wang X, et al. A single-center retrospective cohort study of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma. PloS One. 2022;17:e0275187.","journal-title":"PloS One"},{"key":"17358_CR73","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s00423-022-02594-6","volume":"407","author":"M Acs","year":"2022","unstructured":"Acs M, et al. Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Langenbecks Arch Surg. 2022;407:3057\u201367.","journal-title":"Langenbecks Arch. Surg."},{"key":"17358_CR74","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1177\/000313481508101228","volume":"81","author":"N Aydin","year":"2015","unstructured":"Aydin N, et al. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: experience of a peritoneal surface malignancy center. Am Surg. 2015;81:1253\u20139.","journal-title":"Am. Surg."},{"key":"17358_CR75","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1245\/s10434-017-6293-5","volume":"25","author":"KI Votanopoulos","year":"2018","unstructured":"Votanopoulos KI, et al. Is Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy justified for biphasic variants of peritoneal mesothelioma? Outcomes from the peritoneal surface oncology group international registry. Ann Surg Oncol. 2018;25:667\u201373.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR76","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12032-018-1125-4","volume":"35","author":"SA Naffouje","year":"2018","unstructured":"Naffouje SA, Tulla KA, Salti GI. The impact of chemotherapy and its timing on survival in malignant peritoneal mesothelioma treated with complete debulking. Med Oncol Northwood Lond Engl. 2018;35:69.","journal-title":"Med. Oncol. Northwood Lond. Engl."},{"key":"17358_CR77","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:6237\u201342.","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"17358_CR78","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander","year":"2013","unstructured":"Alexander HR, et al. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013;153:779\u201386.","journal-title":"Surgery"},{"key":"17358_CR79","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1245\/s10434-014-3978-x","volume":"22","author":"JH Helm","year":"2015","unstructured":"Helm JH, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22:1686\u201393.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR80","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.1245\/s10434-017-6033-x","volume":"24","author":"F Le Roy","year":"2017","unstructured":"Le Roy F, et al. Conversion to complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma after bidirectional chemotherapy. Ann Surg Oncol. 2017;24:3640\u20136.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR81","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11605-014-2664-4","volume":"19","author":"S Jin","year":"2015","unstructured":"Jin S, et al. Predictive factors analysis for malignant peritoneal mesothelioma. J Gastrointest Surg. 2015;19:319\u201326.","journal-title":"J. Gastrointest. Surg."},{"key":"17358_CR82","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1245\/s10434-019-07803-z","volume":"26","author":"NL de Boer","year":"2019","unstructured":"de Boer NL, et al. Malignant peritoneal mesothelioma: patterns of care and survival in The Netherlands: a population-based study. Ann Surg Oncol. 2019;26:4222\u20138.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR83","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1245\/s10434-023-13640-y","volume":"31","author":"A Chatterjee","year":"2024","unstructured":"Chatterjee A, et al. Impact of perioperative systemic chemotherapy on survival for patients who have diffuse malignant peritoneal mesothelioma treated with CRS-HIPEC. Ann Surg Oncol. 2024;31:556\u201366.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR84","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/890450","volume":"2012","author":"L Bijelic","year":"2012","unstructured":"Bijelic L, Stuart OA, Sugarbaker P. Adjuvant bidirectional chemotherapy with intraperitoneal pemetrexed combined with intravenous Cisplatin for diffuse malignant peritoneal mesothelioma. Gastroenterol Res Pract. 2012;2012:890450.","journal-title":"Gastroenterol. Res. Pract."},{"key":"17358_CR85","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4240\/wjgs.v1.i1.38","volume":"1","author":"S Munkholm-Larsen","year":"2009","unstructured":"Munkholm-Larsen S, Cao CQ, Yan TD. Malignant peritoneal mesothelioma. World J Gastrointest Surg. 2009;1:38\u201348.","journal-title":"World J. Gastrointest. Surg."},{"issue":"49","key":"17358_CR86","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1016\/j.ejca.2013.05.027","volume":"1990","author":"D Baratti","year":"2013","unstructured":"Baratti D, et al. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC). Eur J Cancer Oxf Engl. 2013;1990(49):3140\u20138.","journal-title":"Eur. J. Cancer Oxf. Engl."},{"key":"17358_CR87","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1245\/s10434-012-2651-5","volume":"20","author":"NP Schaub","year":"2013","unstructured":"Schaub NP, et al. A novel nomogram for peritoneal mesothelioma predicts survival. Ann Surg Oncol. 2013;20:555\u201361.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR88","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.12688\/f1000research.15512.3","volume":"7","author":"W Amin","year":"2019","unstructured":"Amin W, et al. Factors influencing malignant mesothelioma survival: a retrospective review of the National Mesothelioma Virtual Bank cohort. F1000Research. 2019;7:1184.","journal-title":"F1000Research"},{"key":"17358_CR89","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/bjs.5377","volume":"93","author":"TD Yan","year":"2006","unstructured":"Yan TD, Popa E, Brun EA, Cerruto CA, Sugarbaker PH. Sex difference in diffuse malignant peritoneal mesothelioma. Br J Surg. 2006;93:1536\u201342.","journal-title":"Br. J. Surg."},{"key":"17358_CR90","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1093\/annonc\/mdr477","volume":"23","author":"C Cao","year":"2012","unstructured":"Cao C, et al. Importance of gender in diffuse malignant peritoneal mesothelioma. Ann Oncol Off J Eur Soc Med Oncol. 2012;23:1494\u20138.","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"17358_CR91","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"Baumann F, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36:76\u201381.","journal-title":"Carcinogenesis"},{"key":"17358_CR92","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3390\/cancers15010229","volume":"15","author":"L Calthorpe","year":"2022","unstructured":"Calthorpe L, et al. Contemporary trends in malignant peritoneal mesothelioma: incidence and survival in the United States. Cancers. 2022;15:229.","journal-title":"Cancers"},{"key":"17358_CR93","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/diagnostics10060386","volume":"10","author":"F Pezzuto","year":"2020","unstructured":"Pezzuto F, et al. Prognostic value of Ki67 percentage, WT-1 expression and p16\/CDKN2A deletion in diffuse malignant peritoneal mesothelioma: a single-centre cohort study. Diagnostics. 2020;10:386.","journal-title":"Diagnostics"},{"key":"17358_CR94","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1183\/09031936.00153611","volume":"40","author":"RAM Damhuis","year":"2012","unstructured":"Damhuis RAM, Schroten C, Burgers JA. Population-based survival for malignant mesothelioma after introduction of novel chemotherapy. Eur Respir J. 2012;40:185\u20139.","journal-title":"Eur. Respir. J."},{"key":"17358_CR95","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/09537104.2016.1246712","volume":"28","author":"Y Zhuo","year":"2017","unstructured":"Zhuo Y, Lin L, Zhang M. Pretreatment thrombocytosis as a significant prognostic factor in malignant mesothelioma: a meta-analysis. Platelets. 2017;28:560\u20136.","journal-title":"Platelets"},{"key":"17358_CR96","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/cncr.34763","volume":"129","author":"Y Berger","year":"2023","unstructured":"Berger Y, et al. Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation. Cancer. 2023;129:2152\u201360.","journal-title":"Cancer"},{"key":"17358_CR97","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.jtcvs.2022.11.035","volume":"165","author":"RT Ripley","year":"2023","unstructured":"Ripley RT, et al. Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy. J Thorac Cardiovasc Surg. 2023;165:1722\u201330.","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"17358_CR98","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1245\/s10434-019-07409-5","volume":"27","author":"AS Letica-Kriegel","year":"2020","unstructured":"Letica-Kriegel AS, et al. 50 patients with malignant mesothelioma of both the pleura and peritoneum: a single-institution experience. Ann Surg Oncol. 2020;27:205\u201313.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/jso.10081","volume":"79","author":"S Gonz\u00e1lez-Moreno","year":"2002","unstructured":"Gonz\u00e1lez-Moreno S, Yan H, Alcorn KW, Sugarbaker PH. Malignant transformation of \u201cbenign\u201d cystic mesothelioma of the peritoneum. J Surg Oncol. 2002;79:243\u201351.","journal-title":"J. Surg. Oncol."},{"key":"17358_CR100","doi-asserted-by":"crossref","unstructured":"Noiret B, Renaud F, Piessen G, Eveno C. Multicystic peritoneal mesothelioma: a systematic review of the literature. Pleura Peritoneum 2019; 4.","DOI":"10.1515\/pp-2019-0024"},{"key":"17358_CR101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.lungcan.2008.08.013","volume":"64","author":"G Carteni","year":"2009","unstructured":"Carteni G, et al. Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent. Lung Cancer Amst Neth. 2009;64:211\u20138.","journal-title":"Lung Cancer Amst. Neth."},{"key":"17358_CR102","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","volume":"387","author":"G Zalcman","year":"2016","unstructured":"Zalcman G, et al. Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial. The Lancet. 2016;387:1405\u201314.","journal-title":"The Lancet"},{"key":"17358_CR103","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","volume":"397","author":"P Baas","year":"2021","unstructured":"Baas P, et al. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. The Lancet. 2021;397:375\u201386.","journal-title":"The Lancet"},{"key":"17358_CR104","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.19934","volume":"4","author":"K Raghav","year":"2021","unstructured":"Raghav K, et al. Clinical efficacy of immune checkpoint inhibitors in patients with advanced malignant peritoneal mesothelioma. JAMA Netw Open. 2021;4:e2119934.","journal-title":"JAMA Netw. Open"},{"key":"17358_CR105","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s10147-008-0839-2","volume":"14","author":"S Tanida","year":"2009","unstructured":"Tanida S, et al. Combination chemotherapy with cisplatin and gemcitabine in malignant peritoneal mesothelioma. Int J Clin Oncol. 2009;14:266\u20139.","journal-title":"Int. J. Clin. Oncol."},{"key":"17358_CR106","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/sj.bjc.6600505","volume":"87","author":"AK Nowak","year":"2002","unstructured":"Nowak AK, et al. A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma. Br J Cancer. 2002;87:491\u20136.","journal-title":"Br. J. Cancer"},{"key":"17358_CR107","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1200\/JCO.2007.15.2868","volume":"26","author":"GR Simon","year":"2008","unstructured":"Simon GR, et al. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:3567\u201372.","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"17358_CR108","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.lungcan.2008.09.008","volume":"64","author":"CW Lee","year":"2009","unstructured":"Lee CW, Murray N, Anderson H, Rao SC, Bishop W. Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia. Lung Cancer Amst Neth. 2009;64:308\u201313.","journal-title":"Lung Cancer Amst. Neth."},{"key":"17358_CR109","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ctrv.2015.10.006","volume":"41","author":"GL Ceresoli","year":"2015","unstructured":"Ceresoli GL, Zucali PA. Vinca alkaloids in the therapeutic management of malignant pleural mesothelioma. Cancer Treat Rev. 2015;41:853\u20138.","journal-title":"Cancer Treat. Rev."},{"key":"17358_CR110","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","volume":"11","author":"R Govindan","year":"2005","unstructured":"Govindan R, et al. Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Clin Cancer Res Off J Am Assoc Cancer Res. 2005;11:2300\u20134.","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"17358_CR111","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12885-021-08025-x","volume":"21","author":"R Kitadai","year":"2021","unstructured":"Kitadai R, et al. Efficacy of second-line treatment and prognostic factors in patients with advanced malignant peritoneal mesothelioma: a retrospective study. BMC Cancer. 2021;21:294.","journal-title":"BMC Cancer"},{"key":"17358_CR112","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1158\/2159-8290.CD-21-0331","volume":"11","author":"K Raghav","year":"2021","unstructured":"Raghav K, et al. Efficacy, Safety, and Biomarker Analysis of Combined PD-L1 (Atezolizumab) and VEGF (Bevacizumab) Blockade in Advanced Malignant Peritoneal Mesothelioma. Cancer Discov. 2021;11:2738\u201347.","journal-title":"Cancer Discov."},{"key":"17358_CR113","doi-asserted-by":"publisher","first-page":"9013","DOI":"10.1200\/JCO.2020.38.15_suppl.9013","volume":"38","author":"KPS Raghav","year":"2020","unstructured":"Raghav KPS, et al. A phase II trial of atezolizumab and bevacizumab in patients with relapsed\/refractory and unresectable malignant peritoneal mesothelioma. J Clin Oncol. 2020;38:9013\u20139013.","journal-title":"J. Clin. Oncol."},{"key":"17358_CR114","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/S1470-2045(21)00404-6","volume":"22","author":"C Pinto","year":"2021","unstructured":"Pinto C, et al. Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2021;22:1438\u201347.","journal-title":"Lancet Oncol."},{"key":"17358_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101432","volume":"48","author":"DA Fennell","year":"2022","unstructured":"Fennell DA, et al. Active symptom control with or without oral vinorelbine in patients with relapsed malignant pleural mesothelioma (VIM): A randomised, phase 2 trial. EClinicalMedicine. 2022;48:101432.","journal-title":"EClinicalMedicine"},{"key":"17358_CR116","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/S1470-2045(20)30462-9","volume":"21","author":"AK Nowak","year":"2020","unstructured":"Nowak AK, et al. Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in. Lancet Oncol. 2020;21:1213\u201323.","journal-title":"Lancet Oncol."},{"key":"17358_CR117","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1038\/s41591-021-01541-0","volume":"27","author":"PM Forde","year":"2021","unstructured":"Forde PM, et al. Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial. Nat Med. 2021;27:1910\u201320.","journal-title":"Nat. Med."},{"key":"17358_CR118","doi-asserted-by":"publisher","first-page":"BAL8505","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA8505","volume":"41","author":"QS Chu","year":"2023","unstructured":"Chu QS, et al. IND227 phase III (P3) study of cisplatin\/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): a CCTG, NCIN, and IFCT trial. J Clin Oncol. 2023;41:BAL8505-LBA8505.","journal-title":"J. Clin. Oncol."},{"key":"17358_CR119","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1245\/s10434-023-13528-x","volume":"30","author":"L Calthorpe","year":"2023","unstructured":"Calthorpe L, et al. National practice patterns in malignant peritoneal mesothelioma: updates in management and survival. Ann Surg Oncol. 2023;30:5119\u201329.","journal-title":"Ann. Surg. Oncol."},{"key":"17358_CR120","doi-asserted-by":"publisher","first-page":"11700","DOI":"10.3748\/wjg.v20.i33.11700","volume":"20","author":"A Raza","year":"2014","unstructured":"Raza A, Huang W-C, Takabe K. Advances in the management of peritoneal mesothelioma. World J Gastroenterol WJG. 2014;20:11700\u201312.","journal-title":"World J. Gastroenterol. WJG"},{"key":"17358_CR121","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Mesothelioma: Peritoneal. Version 1.2024. 2024; https:\/\/www.nccn.org\/professionals\/physician_gls\/pf\/meso_peritoneal.pdf."},{"key":"17358_CR122","doi-asserted-by":"publisher","first-page":"7803","DOI":"10.1245\/s10434-023-13973-8","volume":"30","author":"V Kepenekian","year":"2023","unstructured":"Kepenekian V, et al. 2022 PSOGI consensus on HIPEC regimens for peritoneal malignancies: diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2023;30:7803\u201313.","journal-title":"Ann. Surg. Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17358-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17358-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T20:02:43Z","timestamp":1778875363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17358-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":122,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["17358"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17358-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Kanwal Raghav has received advisory board or consulting fees from AstraZeneca, Bayer, Eisai, Daiichi Sankyo, Seattle Genetics, outside the submitted work. John Hays has received advisory board or consulting fees from AstraZeneca, Merck, Tesaro, Clovis Oncology, Deciphera, Ipsen, outside of the submitted work. Marjorie Zauderer has received consulting fees from Ikena, Takeda, GlaxoSmithKline, Alderya Therapeutics, and Novocure, outside of the submitted work. Hedy Kindler has received fees from AstraZeneca, Bayer, Ingelheim, Bristol-Myers Squibb, Kyowa, Merck, Novocure, Paredox Therapeutics, Deciphera, Inhibrx, Inventiva, Aduro, Glaxo Smith Kline, Harpoon, Lilly, Polaris, Verastem, Tesaro, outside the submitted work. Other authors have no relevant financial disclosures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"During the preparation of this work the authors used a large language model (ChatGPT V3.5) to revise the manuscript text for coherence and clarity. After using this service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-assisted technologies in the writing process"}}]}}